Biomolecular Life Holdings annual shares outstanding
2013
2014
Biomolecular Life Holdings Shares Outstanding History (BIOM)
Biomolecular Life Holdings reported 46.2M shares outstanding at the end of fiscal 2014.
View full Biomolecular Life Holdings company overviewBiomolecular Life Holdings annual shares outstanding history
| Fiscal year | Period ended | Shares outstanding | Change | Growth |
|---|---|---|---|---|
| 2014 | 2014-12-31 | 46.2M | 28.8M | +164.74% |
| 2013 | 2013-12-31 | 17.5M | — | — |
Biomolecular Life Holdings quarterly shares outstanding
Q4.13
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
| Fiscal quarter | Period ended | Shares outstanding | Change | YoY change |
|---|---|---|---|---|
| Q3 2015 | 2015-09-30 | 101.5M | 70.3M | +225.01% |
| Q2 2015 | 2015-06-30 | 77.3M | — | — |
| Q1 2015 | 2015-03-31 | 61.5M | — | — |
| Q4 2014 | 2014-12-31 | 46.2M | 28.8M | +164.74% |
| Q3 2014 | 2014-09-30 | 31.2M | — | — |
| Q4 2013 | 2013-12-31 | 17.5M | — | — |
Biomolecular Life Holdings shares outstanding trends
Between the periods ended 2013-12-31 and 2014-12-31, Biomolecular Life Holdings's shares outstanding moved from 17.5M to 46.2M, a change of 28.8M. The latest reported quarter, Q3 2015, shows 101.5M.
About the metric
What shares outstanding means
Shares outstanding is the number of common shares held by investors at a reporting-period end. The count can change because of stock issuance, repurchases, conversions, acquisitions, or stock splits.
Calculation and source
SEC-reported period-end shares
TickerStat displays period-end common shares from SEC filings and adjusts older values to the current share basis when a stock-split conversion ratio is reported directly or evidenced by a later filing’s restated historical share balance. After repeated reverse splits, an old period can represent less than one current-basis share; this is a split-adjusted equivalent, not a literal historical certificate count. Values remain as reported when no reliable split ratio is available. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Biomolecular Life Holdings source filings ↗